Pacer Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.04M | Buy |
|
|||||
|
2025
Q2 | $344K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $914K | Sell |
|
|||||
|
2024
Q3 | $941K | Buy |
|
|||||
|
2024
Q2 | $704K | Buy |
|
|||||
|
2024
Q1 | $503K | Buy |
|
|||||
|
2023
Q4 | $458K | Sell |
|
|||||
|
2023
Q3 | $1.56M | Buy |
|
|||||
|
2023
Q2 | $1.41M | Buy |
|
|||||
|
2023
Q1 | $935K | Buy |
|
|||||
|
2022
Q4 | $150K | Sell |
|
|||||
|
2022
Q3 | $584K | Buy |
|
|||||
|
2022
Q2 | $648K | Sell |
|
|||||
|
2022
Q1 | $1.18M | Buy |
|
|||||
|
2021
Q4 | $875K | Sell |
|
|||||
|
2021
Q3 | $1.49M | Sell |
|
|||||
|
2021
Q2 | $1.48M | Buy |
|
|||||
|
2021
Q1 | $695K | Sell |
|
|||||
|
2020
Q4 | $823K | Sell |
|
|||||
|
2020
Q3 | $1.3M | Sell |
|
|||||
|
2020
Q2 | $1.31M | Buy |
|
|||||
|
2020
Q1 | $14K | Sell |
|
|||||
|
2019
Q4 | $2.72M | Sell |
|
|||||
|
2019
Q3 | $2.58M | Sell |
|
|||||
|
2019
Q2 | $2.52M | Buy |
|
|||||
|
2019
Q1 | $12K | Sell |
|
|||||
|
2018
Q4 | $20K | Sell |
|
|||||
|
2018
Q3 | $2.27M | Buy |
|
|||||
|
2018
Q2 | $1.85M | Buy |
|
|||||
|
2018
Q1 | $1.38M | Buy |
|
|||||
|
2017
Q4 | $1.16M | Buy |
|
|||||
|
2017
Q3 | $838K | Buy |
|
|||||
|
2017
Q2 | $748K | Buy |
|
|||||
|
2017
Q1 | $565K | Buy |
|
|||||
|
2016
Q4 | $392K | Buy |
|
|||||
|
2016
Q3 | $318K | Buy |
|
|||||
|
2016
Q2 | $254K | Buy |
|